MHC Class II: a Predictor of Outcome in Melanoma Treated with Immune Checkpoint Inhibitors.
Melanoma research（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined